214 related articles for article (PubMed ID: 18006607)
1. Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation?
Lo CM; Nordskog BK; Nauli AM; Zheng S; Vonlehmden SB; Yang Q; Lee D; Swift LL; Davidson NO; Tso P
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G344-52. PubMed ID: 18006607
[TBL] [Abstract][Full Text] [Related]
2. Superior role of apolipoprotein B48 over apolipoprotein B100 in chylomicron assembly and fat absorption: an investigation of apobec-1 knock-out and wild-type mice.
Kendrick JS; Chan L; Higgins JA
Biochem J; 2001 Jun; 356(Pt 3):821-7. PubMed ID: 11389690
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-V deficiency enhances chylomicron production in lymph fistula mice.
Zhang LS; Xu M; Yang Q; Ryan RO; Howles P; Tso P
Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(7):G634-42. PubMed ID: 25617349
[TBL] [Abstract][Full Text] [Related]
4. Is apolipoprotein A-IV rate limiting in the intestinal transport and absorption of triglyceride?
Kohan AB; Wang F; Li X; Vandersall AE; Huesman S; Xu M; Yang Q; Lou D; Tso P
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(12):G1128-35. PubMed ID: 23599044
[TBL] [Abstract][Full Text] [Related]
5. Fat feeding increases size, but not number, of chylomicrons produced by small intestine.
Hayashi H; Fujimoto K; Cardelli JA; Nutting DF; Bergstedt S; Tso P
Am J Physiol; 1990 Nov; 259(5 Pt 1):G709-19. PubMed ID: 2240215
[TBL] [Abstract][Full Text] [Related]
6. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes.
Phillips C; Bennett A; Anderton K; Owens D; Collins P; White D; Tomkin GH
Metabolism; 2002 Jul; 51(7):847-52. PubMed ID: 12077729
[TBL] [Abstract][Full Text] [Related]
7. CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine.
Nauli AM; Nassir F; Zheng S; Yang Q; Lo CM; Vonlehmden SB; Lee D; Jandacek RJ; Abumrad NA; Tso P
Gastroenterology; 2006 Oct; 131(4):1197-207. PubMed ID: 17030189
[TBL] [Abstract][Full Text] [Related]
8. Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes?
Phillips C; Madigan C; Owens D; Collins P; Tomkin GH
Int J Exp Diabetes Res; 2002; 3(3):171-8. PubMed ID: 12458658
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.
Hsieh J; Longuet C; Maida A; Bahrami J; Xu E; Baker CL; Brubaker PL; Drucker DJ; Adeli K
Gastroenterology; 2009 Sep; 137(3):997-1005, 1005.e1-4. PubMed ID: 19482026
[TBL] [Abstract][Full Text] [Related]
10. Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins.
Xie Y; Nassir F; Luo J; Buhman K; Davidson NO
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G735-46. PubMed ID: 12816761
[TBL] [Abstract][Full Text] [Related]
11. Lipid and apolipoprotein B48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats.
Martins IJ; Sainsbury AJ; Mamo JC; Redgrave TG
Diabetologia; 1994 Mar; 37(3):238-46. PubMed ID: 8174836
[TBL] [Abstract][Full Text] [Related]
12. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48.
Hui DY; Innerarity TL; Milne RW; Marcel YL; Mahley RW
J Biol Chem; 1984 Dec; 259(24):15060-8. PubMed ID: 6096356
[TBL] [Abstract][Full Text] [Related]
13. [Intestinal apolipoprotein metabolism].
Steinmetz A
Klin Wochenschr; 1990; 68 Suppl 22():12-8. PubMed ID: 2087069
[TBL] [Abstract][Full Text] [Related]
14. ApoB48 as an Efficient Regulator of Intestinal Lipid Transport.
Lo CC; Coschigano KT
Front Physiol; 2020; 11():796. PubMed ID: 32733283
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.
Morrison JR; Pászty C; Stevens ME; Hughes SD; Forte T; Scott J; Rubin EM
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7154-9. PubMed ID: 8692961
[TBL] [Abstract][Full Text] [Related]
16. Effects of lipid administration on lymphatic apolipoprotein A-IV and B output and synthesis.
Nishimura M; Seishima M; Ohashi H; Noma A
Am J Physiol; 1996 Aug; 271(2 Pt 1):G322-9. PubMed ID: 8770048
[TBL] [Abstract][Full Text] [Related]
17. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.
Smith D; Watts GF; Dane-Stewart C; Mamo JC
Eur J Clin Invest; 1999 Mar; 29(3):204-9. PubMed ID: 10202376
[TBL] [Abstract][Full Text] [Related]
18. Effects of apo E deficiency on plasma lipid levels in mice lacking APOBEC-1.
Osuga J; Yagyu H; Ohashi K; Harada K; Yazaki Y; Yamada N; Ishibashi S
Biochem Biophys Res Commun; 1997 Jul; 236(2):375-8. PubMed ID: 9240444
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia.
Sandoval JC; Nakagawa-Toyama Y; Masuda D; Tochino Y; Nakaoka H; Kawase R; Yuasa-Kawase M; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Ohama T; Matsuyama A; Nishida M; Ishigami M; Komuro I; Yamashita S
J Atheroscler Thromb; 2010 Sep; 17(9):914-24. PubMed ID: 20543519
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function.
Kohan AB; Wang F; Li X; Bradshaw S; Yang Q; Caldwell JL; Bullock TM; Tso P
Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(6):G628-36. PubMed ID: 22207575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
